Owlet (OWLT) Income from Continuing Operations (2020 - 2026)
Owlet (OWLT) posted quarterly Income from Continuing Operations of 3336000.0 for Q1 2026, down 210.28% year-over-year from 3025000.0 in Q1 2025, and up 63.7% quarter-over-quarter from 9190000.0 in Q4 2025.
Owlet (OWLT) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Owlet (OWLT) has reported Income from Continuing Operations for 7 consecutive years, with 3336000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 210.28% year-over-year to 3336000.0; the TTM figure through Mar 2026 stood at 46039000.0 (down 260.1% YoY), while the FY2025 annual figure was 39678000.0, down 216.51% from the prior year.
- Income from Continuing Operations advanced to 3336000.0 in Q1 2026 per OWLT's latest filing, from 9190000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 4134000.0 in Q3 2025 and bottomed at 37647000.0 in Q2 2025.
- Historically, Income from Continuing Operations has averaged 9869823.53 across 5 years, with a median of 8467000.0 in 2023.
- On a YoY basis, Income from Continuing Operations climbed as much as 173.68% in 2025 and fell as far as 3182.21% in 2025.
- Owlet's Income from Continuing Operations stood at 19498000.0 in 2022, then soared by 64.48% to 6926000.0 in 2023, then sank by 30.7% to 9052000.0 in 2024, then dropped by 1.52% to 9190000.0 in 2025, then jumped by 63.7% to 3336000.0 in 2026.
- Business Quant data shows OWLT's Income from Continuing Operations at 3336000.0 in Q1 2026, 9190000.0 in Q4 2025, and 4134000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Owlet | 164.96 Mn | 128.41 Mn | 21.82 Mn | -620,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -620,000.00 |
| Mar 31, 2026 | -3.34 Mn |
| Dec 31, 2025 | -9.19 Mn |
| Sep 30, 2025 | 4.13 Mn |
| Jun 30, 2025 | -37.65 Mn |
| Mar 31, 2025 | 3.03 Mn |
| Dec 31, 2024 | -9.05 Mn |
| Sep 30, 2024 | -5.61 Mn |
| Jun 30, 2024 | -1.15 Mn |
| Mar 31, 2024 | 3.27 Mn |
| Dec 31, 2023 | -6.93 Mn |
| Sep 30, 2023 | -5.64 Mn |
| Jun 30, 2023 | -8.47 Mn |
| Mar 31, 2023 | -11.87 Mn |
| Dec 31, 2022 | -19.50 Mn |
| Sep 30, 2022 | -19.36 Mn |
| Jun 30, 2022 | -11.72 Mn |
| Mar 31, 2022 | -28.76 Mn |
| Dec 31, 2021 | -24.06 Mn |
| Sep 30, 2021 | -34.46 Mn |